Jan. 7, 2024
Isomorphic Labs, a digital biology company specializing in AI applications, has entered into two distinct research collaborations with Eli Lilly …
Jan. 7, 2024
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a …
Jan. 6, 2024
ReCode Therapeutics, a leader in genetic medicines, is pioneering a promising avenue in the treatment of primary ciliary dyskinesia (PCD) …
Jan. 5, 2024
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
Jan. 4, 2024
In a new development in oncology, the Menarini Group and Insilico Medicine have announced an exclusive global licensing agreement. This …
Jan. 4, 2024
C4X Discovery Holdings plc (AIM: C4XD), a drug discovery company, recently announced a significant milestone in its partnership with AstraZeneca. …
Jan. 3, 2024
InVivo Biosystems, operating in the realm of CRISPR-edited animal models for biomedical research, has recently embarked on a new phase …
Jan. 3, 2024
Executives from the French AI drug discovery company Owkin have embarked on a new venture, launching Bioptimus, a startup dedicated …
Dec. 28, 2023
Sponsored by Lantern Pharma
The sphere of oncology continues to grapple with the complex nature of brain and central nervous system (CNS) tumors. Data …
Dec. 28, 2023
In a significant development in the pharmaceutical industry, Bristol Myers Squibb (BMS) has announced the acquisition of RayzeBio, a company …
Dec. 27, 2023
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …
Dec. 26, 2023
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
